You are here: Welcome » Genome British Columbia

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
genome_british_columbia [2022/04/18 21:59]
liam
genome_british_columbia [2022/09/12 22:53] (current)
liam [Affiliations]
Line 9: Line 9:
 ===== Affiliations ===== ===== Affiliations =====
  
-Genome BC is a partner organization of the [[Canadian COVID Genomics Network]] (CANCoGEN).((//CanCOGeN Partners.// Genome Canada. Retrieved February 9, 2022, from https://archive.ph/KcLqD))+Genome BC is a partner organization of the [[Canadian COVID-19 Genomics Network]] (CANCoGEN).((//CanCOGeN Partners.// Genome Canada. Retrieved February 9, 2022, from https://archive.ph/KcLqD))
  
 ==== Industry ==== ==== Industry ====
  
-Genome BC has helped fund and launch several biopharmaceutical companies including [[pharmaceutical_companies:AbCellera]], [[medical_technology_companies:Acuva]], [[medical_technology_companies: ALAViDA]], [[pharmaceutical_companies:Anandia Labs]], [[pharmaceutical_companies:Aspect Biosystems]], [[medical_technology_companies:Augurex]], [[medical_technology_companies:Boreal Genomics]], [[medical_technology_companies:Contextual Genomics]], [[medical_technology_companies:GenXys]], [[medical_technology_companies:MRM Proteonomics]], [[pharmaceutical_companies:Precision NanoSystems]], [[medical_technology_companies:Sonic Incytes]], and [[medical_technology_companies:Starling Minds]].((((//Annual Report 2020-2021.// Genome BC. Retrieved April 18, 2022, from https://web.archive.org/web/20210703114654/https://www.genomebc.ca/wp-content/uploads/2021/06/GBC-5198-2020-21-AR-FINAL_WEB.pdf))))+Genome BC has helped fund and launch several biopharmaceutical companies including [[pharmaceutical_companies:AbCellera]], [[medical_technology_companies:Acuva]], [[medical_technology_companies: ALAViDA]], [[pharmaceutical_companies:Anandia Labs]], [[pharmaceutical_companies:Aspect Biosystems]], [[medical_technology_companies:Augurex]], [[medical_technology_companies:Boreal Genomics]], [[medical_technology_companies:Contextual Genomics]], [[medical_technology_companies:GenXys]], [[medical_technology_companies:MRM Proteonomics]], [[pharmaceutical_companies:Precision NanoSystems]], [[medical_technology_companies:Sonic Incytes]], and [[medical_technology_companies:Starling Minds]].((//Annual Report 2020-2021.// Genome BC. Retrieved April 18, 2022, from https://web.archive.org/web/20210703114654/https://www.genomebc.ca/wp-content/uploads/2021/06/GBC-5198-2020-21-AR-FINAL_WEB.pdf))
Back to top